Tag: pharmaceuticals
-

Int’l Group Funding Coronavirus Vaccines
An international health coalition is funding development of vaccines against the new coronavirus outbreak spreading quickly through China and to other countries.
-

FDA Clears Placenta Cell Brain Cancer Trial
A company developing cancer therapies with stem cells from human placentas says FDA cleared its request to start a clinical trial of a treatment for brain cancer.
-

Many Non-Cancer Drugs Found to be Cancer Fighters
A systematic high-speed screen of more than 4,500 drugs on hundreds of cancer cell lines finds 49 approved drugs for a range of diseases are also able to treat cancer.
-

Protein Tags Devised to Stop Counterfeit Drugs
A bio-engineering lab developed a tiny edible tag from natural proteins that uniquely identifies individual doses of medicines to prevent counterfeiting.
-

UPMC to Invest $1 Billion in Medical Enterprises
UPMC, the medical center affiliated with University of Pittsburgh, plans to invest $1 billion in life science advances, with spin-off companies as part of its strategy.
-

Venture Philanthropy Funds Rare Neuro Disease Trial
A gene therapy start-up is receiving an award resembling venture financing to advance its treatment for a rare inherited neuromuscular disorder to clinical trials.
-

New Biotech Aims to Bring Down Drug Prices
A biotechnology company launched yesterday that plans to discover and develop therapies faster and at lower cost than many of today’s new drugs.
-

Pharma Gains Fibrosis Technology in $1B+ Deal
Drug maker Boehringer Ingelheim is acquiring an antibody technology that blocks actions of a signaling protein associated with a range of fibrosis diseases.
-

Vaccine Developer Gains $11M in Early Funds
A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round.
-

Trial Underway Testing Crispr-Based Antibiotic
A clinical trial is recruiting participants to test an antibiotic made with engineered viruses, in people threatened with urinary tract infections from E. coli bacteria.